Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Darbepoetin Plus Slow-release Intravenous Iron to Decrease Transfusions and Improve Iron Status and Neurodevelopment in Preterm Infants

NCT05340465 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT05340465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05340465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Darbepoetin Plus Slow-release Intravenous Iron to Decrease Transfusions and Improve Iron Status and Neurodevelopment in Preterm Infants
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Recruiting
Start date
November 27, 2022
Completion date
June 30, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency anemia, iron malabsorption, iron-deficiency, prematurity